GPC3 and neoplasm: Tseng et al. devised a logic-gated GPC3-synNotch-inducible CD147-CAR-T system capable of selectively attacking GPC3+CD147+ HCC cells in transgenic mouse models with minimized on-target/off-tumor toxicity [46].